Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM) - M. Janning, J. Süptitz, C. Albers-Leischner, P. Delpy, A. Tufman, J.-L. Velthaus-Rusik, M. Reck, A. Jung, D. Kauffmann-Guerrero, I. Bonzheim, S. Brändlein, H.-D. Hummel, M. Wiesweg, H.-U. Schildhaus, J. A. Stratmann - Dissemin

Language
Login

Published in

Elsevier, Annals of Oncology, 6(33), p. 602-615, 2022

DOI: 10.1016/j.annonc.2022.02.225

Links

Tools

Export citation

Search in Google Scholar

Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)

Journal article published in 2022 by M. Janning, J. Süptitz, C. Albers-Leischner, P. Delpy, A. Tufman, J.-L. Velthaus-Rusik, M. Reck, A. Jung, D. Kauffmann-Guerrero, I. Bonzheim, S. Brändlein, H.-D. Hummel, M. Wiesweg, H.-U. Schildhaus, J. A. Stratmann and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO